Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03763123
What this trial is testing

A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.

Who this might be right for
Ovarian Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 48
Large-scale testing (Phase 3)Ended earlyNCT01840943
What this trial is testing

Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Who this might be right for
Epithelial Ovarian Cancer
Xian-Janssen Pharmaceutical Ltd. 32
Early research (Phase 1)Looking for participantsNCT03604315
What this trial is testing

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Who this might be right for
Breast CarcinomaFallopian Tube CarcinomaOvarian Carcinoma+5 more
M.D. Anderson Cancer Center 300
Early research (Phase 1)Study completedNCT01256268
What this trial is testing

Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids

Who this might be right for
Endometrial CancerOvarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 24
Early research (Phase 1)Study completedNCT00408590
What this trial is testing

Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Mayo Clinic 37
Testing effectiveness (Phase 2)Ended earlyNCT00312650
What this trial is testing

Doxil and Gemcitabine in Recurrent Ovarian Cancer

Who this might be right for
Ovarian Carcinoma
Women and Infants Hospital of Rhode Island 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370818
What this trial is testing

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Onconic Therapeutics Inc. 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06544460
What this trial is testing

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

Who this might be right for
Ovarian Cancer
Fudan University 94
Testing effectiveness (Phase 2)WithdrawnNCT00562185
What this trial is testing

Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Texas Southwestern Medical Center
Not applicableNot Yet RecruitingNCT06925126
What this trial is testing

Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 200
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00054119
What this trial is testing

Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal CarcinomaRecurrent Ovarian Carcinoma
Gynecologic Oncology Group 27
Early research (Phase 1)Active Not RecruitingNCT05156892
What this trial is testing

Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anthony Joshua, FRACP 44
Large-scale testing (Phase 3)Looking for participantsNCT06394492
What this trial is testing

SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 440
Testing effectiveness (Phase 2)Study completedNCT02889900
What this trial is testing

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
AstraZeneca 62
Early research (Phase 1)Study completedNCT02275039
What this trial is testing

P53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01767675
What this trial is testing

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tubes CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 99
Not applicableStudy completedNCT05188781
What this trial is testing

Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer

Who this might be right for
High-Grade Serous Ovarian Cancer
The Affiliated Hospital of Qingdao University 34
Large-scale testing (Phase 3)Ended earlyNCT00002819
What this trial is testing

Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group
Early research (Phase 1)Looking for participantsNCT05316129
What this trial is testing

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 10
Next Page